Chester 01244 405555

Grosvenor Court
Foregate Street Chester
Cheshire CH1 1HG
DX: 19990 Chester

Shrewsbury 01743 443 043

Lakeside House
Oxon Business Park
Shrewsbury SY3 5HJ
DX: 148563 Shrewsbury 14

Manchester 0844 800 8346

Pall Mall Court
61-67 King Street
Manchester M2 4PD

Send us a message
Our Offices

Aaron & Partners advise Fullbrook Thorpe on multi million pound investment

30th November, 2015

Aaron & Partners has acted for private investment fund Fullbrook Thorpe Investments LLP, which is backed by Andy Leaver (former majority owner of Clinigen Group), in its multi million pound investment in Bionical Limited.

Bionical provides bespoke services for its clients with the aim of becoming the outsource partner of choice for its global pharmaceutical client base.

Fullbrook Thorpe’s investment has provided funding for two recent Bionical acquisitions – Nottingham-based North 51 Group last month and US engagement specialists McCallan Health in August – as well as for further growth capital. This funding facility has been listed on the Channel Islands stock exchange.

Andrew Borkowski, Managing Director of Fullbrook Thorpe Investments, said:

“Bionical is a well-established and respected company in both the UK and the US. It is growing rapidly and providing an increasingly diverse range of truly high quality services to its clients. We are delighted to be playing a significant role in supporting Bionical in this exciting phase of growth.”

Hugh Strickland, Partner in the Corporate Finance team at Aaron & Partners, who advised Fullbrook Thorpe, said:

“It has been really exciting to be involved in such a high profile investment, which has enabled Bionical to increase its services portfolio and will open up further opportunities for the company in the future.”

Ed Bartlett and James Thomas of KPMG Legal in Manchester advised Bionical, with support from Ogiers in the Channel Islands.

For more information please contact the marketing department on 01244 405555 or email [email protected]

You might also be interested in...

Why there is more to CSR than just boosting a company’s ego

6th July, 2018

When a business invests in its community it deserves praise – but it must go beyond that, writes Helen Watson, a trustee at Claire House and partner at Aaron and Partners Solicitors. Corporate social responsibility (CSR) is the link between a company and the community in which it operates. As a trustee on charity boards including Claire House... Read More »

Stuart Haynes reports on IAG Global – Wiesbaden 14th to 17th June 2018

4th July, 2018

Stuart Haynes, Corporate & Commercial Partner and IAG Global Board Member, reports on IAG Global – Wiesbaden held 14th to 17th June 2018 Stuart Haynes (IAG Global Board Member) Stuart Scott-Goldstone and Nick Clarke attended the recent IAG Global meeting in Wiesbaden which was held at the Grand Hotel Nassauer Hof from 14th – and 17th July 2018 The meeting... Read More »

DNA Test ordered in inheritance dispute where paternity questioned

6th June, 2018

Rhiannon Edwards, Solicitor in the Wills, Trusts and Tax department, discusses the recent judgement in the case of Nield-Moir v Freeman, where the High Court has ordered one of two daughters of Colin Birtles, who has died, to take a DNA test to prove paternity as part of an inheritance dispute In an unusual case, the High Court... Read More »

Contact Us